Clinical characteristics and risk factors of severe respiratory syncytial virus-associated acute lower respiratory tract infections in hospitalized infants

World Journal of Pediatrics

Volumn 10, Issue 4, 2014, Pages 360-364

  Zhang, Xiao Bo ^a   Liu, Li Juan ^a   Qian, Li Ling ^a   Jiang, Gao Li ^a   Wang, Chuan Kai ^a   Jia, Pin ^a   Shi, Peng ^a   Xu, Jin ^a   Wang, Li Bo ^a  

^a CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

infant; respiratory infectious diseases; respiratory syncytial virus

Indexed keywords

ALLERGIC RHINITIS; APNEA; ARTICLE; ATOPIC DERMATITIS; BRONCHITIS; CHINA; CLINICAL FEATURE; CONGENITAL HEART DISEASE; COUGHING; CRACKLE; CYANOSIS; DISEASE SEVERITY; FEMALE; FEVER; GESTATIONAL AGE; HOSPITAL READMISSION; HOSPITALIZED INFANT; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; INFANT; INFANT DISEASE; INFANT MORTALITY; INVESTIGATIVE PROCEDURES; LOW BIRTH WEIGHT; LOWER RESPIRATORY TRACT INFECTION; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PREMATURITY; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEVERE RESPIRATORY SYNCYTIAL VIRUS ASSOCIATED ACUTE LOWER RESPIRATORY TRACT INFECTION; SMALL AIRWAY DISEASE; SPUTUM; TACHYPNEA; WHEEZING; ACUTE DISEASE; CHILD, HOSPITALIZED; EPIDEMIOLOGY; HUMANS; METHODS; POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

ACUTE DISEASE; CHILD, HOSPITALIZED; CHINA; FEMALE; HUMANS; INFANT; MALE; POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84919449230     PISSN: 17088569     EISSN: 18670687     Source Type: Journal    
DOI: 10.1007/s12519-014-0513-x     Document Type: Article

References (22)

1. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010;375:1545–1555.
2. Morris SK, Dzolganovski B, Beyene J, Sung L. A meta-analysis of the effect of antibody therapy for the prevention of severe respiratory syncytial virus infection. BMC Infect Dis 2009;9:106.
3. Resch B. Respiratory syncytial virus infection in high-risk infants — an update on palivizumab prophylaxis. Open Microbiol J 2014;11:71–77.
4. Kong X, Liu C, Shou H, Shen K, Mai Y, Wang S, et al. Correlation between illness severity and risk factors for respiratory syncytial virus infection. Chin J Pediatr 2000;38:603–606.
5. Hon KL, Leung TF, Cheng WY, Ko NMW, Tang WK, Wong WW, et al. Respiratory syncytial virus morbidity, premorbid factors, seasonality, and implications for prophylaxis. J Crit Care 2012;27:464–468.
6. Leung T, Lam D, Miu T, Hon K, Chau C, Ku S, et al. Epidemiology and risk factors for severe respiratory syncytial virus infections requiring pediatric intensive care admission in Hong Kong children. Infection 2014;42:343–350.
7. Zhang T, Zhu Q, Zhang X, Ding Y, Steinhoff M, Black S, et al. Clinical characteristics and direct medical cost of respiratory syncytial virus infection in children hospitalized in Suzhou, China. Pediatr Infect Dis J 2014;33:337–341.
8. Oncel MY, Arayici S, Simsek GK, Calisici E, Erdeve O, Uras N, et al. Risk factors for hospitalization due to lower respiratory tract infection in preterm infants on palivizumab prophylaxis. Iran J Pediatr 2013;23:693–700.
9. Piedimonte G. Respiratory syncytial virus and asthma: speeddating or long-term relationship? Curr Opin Pediatr 2013;25:344–349.
10. Hu Y, Jiang Z. Practical Pediatric Textbook of Fu-tang Zhu, 7th ed. Beijing: People’s Hygiene Publishing, 2005.
11. Subspecialty Group of Respiratory Diseases, Society of Pediatrics, Chinese Medical Association; Editorial Board, Chinese Journal of Pediatrics. Guidelines for management of childhood community acquired pneumonia (for trial implementation). Chin J Pediatr (Chin) 2007;45:83–90.
12. McConnochie KM, Hall CB, Walsh EE, Roghmann KJ. Variation in severity of respiratory syncytial virus infections with subtype. J Pediatr 1990;117:52–62.
13. Jansen AG, Sanders EA, Hoes AW, Van Loon A, Hak E. Influenza-and respiratory syncytial virus-associated mortality and hospitalisations. Eur Respir J 2007;30:1158–1166.
14. Singleton RJ, Bruden D, Bulkow LR. Respiratory syncytial virus season and hospitalizations in the Alaskan Yukon-Kuskokwim Delta. Pediatr Infect Dis J 2007;26:S46–S50.
15. Thorburn K. Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection. Arch Dis Child 2009;94:99–103.
16. Ito H, Osamura T, Nakajima F, Fujiwara D, Kuwabara Y, Yamamoto T, et al. Survey of severe respiratory syncytial virus infection in Kyoto Prefecture from 2003 to 2007. Pediatr Int 2010;52:273–278.
17. Grimwood K, Cohet C, Rich F, Cheng S, Wood C, Redshaw N, et al. Risk factors for respiratory syncytial virus bronchiolitis hospital admission in New Zealand. Epidemiol Infect 2008;136:1333–1341.
18. Castro-Rodríguez JA, Holberg CJ, Wright AL, Halonen M, Taussig LM, Morgan WJ, et al. Association of radiologically ascertained pneumonia before age 3 yr with asthmalike symptoms and pulmonary function during childhood: a prospective study. Am J Respir Crit Care Med 1999;159:1891–1897.
19. Kusel MM, de Klerk NH, Kebadze T, Vohma V, Holt PG, Johnston SL, et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 2007;119:1105–1110.
20. Eriksson M, Bennet R, Nilsson A. Wheezing following lower respiratory tract infections with respiratory syncytial virus and influenza A in infancy. Pediatr Allergy Immunol 2000;11:193–197.
21. Stevens TP, Sinkin RA, Hall CB, Maniscalco WM, McConnochie KM. Respiratory syncytial virus and premature infants born at 32 weeks’ gestation or earlier: hospitalization and economic implications of prophylaxis. Arch Pediatr Adolesc Med 2000;154:55–61.
22. Carbonell-Estrany X, Quero J, Bustos G, Cotero A, Domenech E, Figueras-Aloy J, et al. Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: a prospective study. IRIS Study Group. Pediatr Infect Dis J 2000;19:592–597.